We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > NITI Aayog

News List

Delta Plus Variant is not yet classified as Variant of Concern: Dr VK Paul expresspharma
June 18, 2021
The way forward is to watch for its potential presence in the country and take the appropriate public health response, said Dr Paul.
8-10 months protection possible with COVID-19 vaccine: AIIMS director expresspharma
March 22, 2021
He said the biggest reason for the surge in cases is that people feel the pandemic is over and they are not following COVID-appropriate behaviour.
India ramping up API manufacturing: NITI Aayog CEO expresspharma
September 17, 2020
Indian government is committed to achieving its ''Pharma Vision 2020'', which aims to make the country a global leader in drug discovery, innovation, and drug manufacturing, said Kant.